Beijing morning news Huimin policy should not be ride profit – View – dachiyouxiang

Beijing morning news: Huimin policy should not be "ride profit – View – original title: long term Huimin policy should not be" lift "profit is to develop, norms, strengthen supervision, between the hospital and commercial inspection agency by tunneling channel. The provisions of China to neonatal congenital hypothyroidism and phenylketonuria two heel blood screening project is free. Reporters found that in some public hospitals in newborn genetic metabolic disease screening for a fee at their own expense, the heel blood of nearly a thousand dollars, "ride" national free items, bundling selling. Hidden behind the operation of a gray interest chain for many years. (August 24th "Chengdu daily") as an implementation of the free policy for many years, every baby after birth, the hospital will be routine collecting heel blood, aims at screening out the potential genetic disease of the newborn, through diet therapy for children with early treatment. It can be said that the national implementation of neonatal heel blood screening is the "guardian of the future" policy. However, this Huimin policy has been part of public hospitals, commercial testing agencies to bring a ride profit, and the formation of a gray industrial chain. This one is to discredit, Huimin Huimin policy policy tarnished. In fact, in addition to congenital hypothyroidism and phenylketonuria in two, other expense heel blood screening program, all hospitals and the interests of the company collusion detection. Therefore, the destruction of the country’s policy of benefiting the behavior must be severely punished. On the other hand, a free state project "ride" profit, is a violation of the legitimate rights and interests of the legitimate interests of the families of newborns, the. In children, parents are willing to spend money, plus a lot of information asymmetry, many parents of newborn heel blood screening "at their own expense that will check the project". In fact, dozens of projects at their own expense for the heel blood screening is extremely rare disease detection, almost no positive reaction, even if it is also difficult to detect, track, difficult to treat. Visible, hospital and testing company using the information barriers caused by the fact. For parents, and aggravated the economic burden of parents. To sum up in a word, the public hospitals with commercial companies, bundling expensive test items, obviously belong to excessive detection, and excessive examination, excessive treatment, nature of the excessive use of drugs as bad, or even worse, in violation of the public hospitals, social welfare services to the purpose. In this regard, there must be restraint and regulatory mechanisms. The most basic work to do is to clean up all the public hospital to carry out the project screening of neonatal heel blood screening, banning unnecessary, and widely, reveal to the public, to eliminate information asymmetry between doctors and patients. To do the long-term work is to develop norms, strengthen supervision, blocking the interests of the hospital and commercial testing channels. In Europe and the United States, Japan and South Korea and other countries, a number of genetic diseases of newborn screening has been incorporated into the scope of medical insurance, but in our country, it is more than third party testing agencies to operate, pricing is also more casual. (commissioning editor Dong Xiaowei and Wen Songhui)相关的主题文章: